In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[Q]: PTC Elimination Act This bill amends the Internal Revenue Code to phase out and eventually eliminate the tax credit for production of electricity from renewable resources. The bill repeals the inflation adjustment for current recipients of the tax credit and modifies the "beginning of construction" requirement to require that construction of an eligible project is continuous and makes significant progress. The credit is repealed in its entirety after December 31, 2025. The bill expresses the sense of Congress that the credit should be allowed to expire and should not be extended beyond its expiration date. The bill also reduces the corporate income tax by an applicable percentage based on increases in revenues resulting from this bill.
[A]: PTC Elimination Act

[Q]: Angie Fatino Save Our Children from Meth Act of 2005 - Amends the Controlled Substances Act to direct the Attorney General to transfer to schedule V ephedrine, pseudoephedrine, and phenylpropanolamine. Makes this provision inapplicable with respect to pseudoephedrine when contained in a product that is in a liquid, liquid capsule, or liquid-filled gel capsule, that does not contain more than 360 milligrams of pseudoephedrine, and that is approved under the Federal Food, Drug, and Cosmetic Act (pseudoephedrine contained in such product shall then be considered a list I chemical).

Revises the definition of "regulated transaction" to exclude specified transactions involving drugs or products that the Attorney General determines are being diverted for illicit purposes.

Places restrictions on the sale of list I and schedule V pseudoephedrine products. Requires a registrant of list I products to: (1) place the products where the customers do not have direct access to them; (2) maintain a sales logbook that identifies the products, purchasers, dates, and times of sales; and (3) not sell such a product to persons under age 18. Prohibits a registrant of schedule V products that do not require prescriptions from dispensing such a product to a prospective purchaser under age 18.

Sets penalties for violations.

Prohibits any person from knowingly or intentionally purchasing at retail: (1) more than one list I pseudoephedrine product during a 24-hour period without a prescription; (2) more than 7,500 milligrams of pseudoephedrine in list I or schedule V products during a 30-day period without a prescription; or (3) such a list I product without legibly signing the appropriate logbook.
[A]: To amend the Controlled Substances Act to provide for the transfer of ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances, and for other purposes.

[Q]: Lyme and Infectious Disease Information and Fairness in Treatment (LIFT) Act - Establishes the Tick-Borne Disorders Advisory Committee in the Office of the Secretary of Health and Human Services (HHS). Directs the Committee to advise the Secretary and the Assistant Secretary of HHS and the Social Security Administration (SSA) Commissioner regarding how to: (1) provide public input on the public's needs regarding tick-borne disorders (lyme and other infectious diseases) so that government agencies can coordinate and more effectively plan and execute their activities; and (2) develop informed responses to constituency groups regarding the efforts and progress of the HHS and SAA.Authorizes appropriations to the Centers for Disease Control and Prevention to: (1) focus on developing better diagnostic tools and tests, expanding educational efforts, and re-educating clinicians, medical license boards, and health care insurers about the inappropriate uses of the Lyme disease case surveillance definition in patient diagnosis and treatment; and (2) collaborate with the National Institutes of Health, the Department of Defense, and other appropriate agencies for further research on tick-borne disorders, including study of preventive methods to decrease exposure to them.Requires the Director of the National Institutes of Health to coordinate activities and research regarding tick-borne diseases across Institutes to encourage collaborative research.
[A]:
To establish a Tick-Borne Disorders Advisory Committee, and for other purposes.